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Abstract
Background: Cervical cancer, although largely preventable, remains the most common cause of cancer mortality
among women in low-resource countries.
The objective of this study was to assess knowledge and awareness of cervical cancer prevention among
Cameroonian healthcare workers.
Methods: A cross-sectional self-administered questionnaire in 5 parts with 46 items regarding cervical cancer
etiology and prevention was addressed to healthcare workers in six hospitals of Yaoundé, Cameroon. The
investigators enlisted heads of nursing and midwifery to distribute questionnaires to their staff, recruited doctors
individually, in hospitals and during conferences and distributed questionnaires to students in Yaoundé University
Hospital and Medical School. Eight hundred and fifty questionnaires were distributed, 401 collected. Data were
analyzed with SPSS version 16.0. Chi-square tests were used and P-values < 0.05 were considered significant.
Results: Mean age of respondents was 38 years (range 20-71 years). Most participants were aware that cervical
cancer is a major public health concern (86%), were able to identify the most important etiological factors (58%)
and believed that screening may prevent cervical cancer (90%) and may be performed by Pap test (84%). However,
less than half considered VIA or HPV tests screening tests (38 and 47%, respectively). Knowledge about cancer
etiology and screening was lowest among nurse/midwives.
Conclusion: Knowledge of cervical cancer and prevention by screening showed several gaps and important
misconceptions regarding screening methods.
Creating awareness among healthcare workers on risk factors and current methods for cervical cancer screening is
a necessary step towards implementing effective prevention programs.
Background
Worldwide, cervical cancer is the second most common
cancer among women, after breast cancer. Every year,
500 000 new cases are diagnosed and 270 000 women die
of this disease, mostly (85%) in developing countries [1].
The world pattern of cervical cancer indicates that this is
predominantly a problem of low resource setting coun-
tries. The main reason is limited access to screening and
treatment facilities [2]. Countries that have organized
screening programs have substantially reduced cervical
cancer incidence and mortality. Screening programs have
the potential to be effective because cervical cancer is
easily accessible to biopsy, there is a long latent period
easily recognizable before development of cancer and
there is an effective treatment in precursor disease.
In 2007, the Cameroonian population was estimated at
18 468 000 inhabitants, with an annual growth rate of
2.2% and crude birth rate of 35‰ [2]. About the half of
the Cameroonian population is female (51%), and the life
expectancy is about 53 years [3]. Women in their forties
have on average 7 children and 21% of them have their
first child when they are teenagers [3,4]. Approximately
6% of the population aged 15-49 is infected with HIV [5].
There is a national cervical cancer-screening program,
but the service is limited to some main cities, and this
probably contributes to the high incidence and mortality
from cervical cancer in a country where 42% of the popu-
lation is rural [2]. Based on hospital registry data, women
most at risk for cervical cancer are those over 35 years
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having an advanced and incurable disease at presentation
[6]. The Cameroon Ministry of Health launched an
awareness and educational campaign in the mass media
and distributed information on the availability of cervical
cancer screening. The method of screening was not spe-
cified but the tests (cytology-based or visual inspection
with acetic acid (VIA)) were offered free of charge to the
population.
Recent years have also seen significant developments in
cervical cancer prevention. Previous efforts to implement
cytology-based screening in developing countries have
been conducted since the early 1980’s. However, to date,
they have failed to reduce the mortality rates mainly
because of inadequate material resources, absence of a
quality control system, lack of trained providers and of
follow-up and treatment facilities.
Lack of knowledge about cervical cancer in the popula-
tion and among healthcare workers is a prime barrier for
access to cervical cancer prevention [6-8]. Our aim was to
assess the knowledge and awareness of cervical cancer
prevention among Cameroonian healthcare workers.
Methods
The National Ethics Committee of Cameroon in Yaoundé
approved the study and authorizations were obtained from
hospital directors involved in the study. Between 1
st and
30 June 2009, 850 questionnaires were distributed and 401
collected in six public hospitals in Yaoundé (Yaoundé
University Hospital, Central Hospital, General Hospital,
Gyneco-Obstetric and Pediatric Hospital, Essos Hospital
and Djoungolo Hospital). These were self-administered,
anonymous, multiple-choice questionnaires, addressed to
healthcare workers in contact with women (GPs, nurses,
midwifes, pediatricians, gynecologists and obstetricians).
Each participant received written explanations about the
objectives of the study.
The investigators recruited most doctors and students
individually, while nurses were contacted by head-nurses
of the department. The questionnaire contained 46 multi-
ple-choice questions (with « yes », « no », « I don’t know
» answers) covering the following topics: (i) knowledge of
epidemiology of cervical cancer; (ii) risk factors; (iii) HPV
infection and link to cervical cancer; (iv) screening meth-
ods and practices and (v) demographics and socio-profes-
sional questions. The data collected were analyzed using
the statistical analysis program SPSS version 16.0. Chi-
square tests were used and P-values < 0.05 were consid-
ered significant.
Results
Median age of the respondents was 38 years; 95% of
them were or had been sexually active. Other demo-
graphic characteristics of respondents are depicted in
Table 1. Most respondents (86%) agreed that cervical
cancer is one of the two most common cancers in
Cameroonian women, and identified it as a major public
health concern for the country.
The causative link between high-risk human papillo-
mavirus (HPV) and cervical cancer was well identified
by most respondents (Table 2). On the other hand, only
45% were aware that HIV infection is a risk factor for
HPV infection and cervical cancer. Multiple sexual part-
ners was correctly identified as being a risk factor by
71% of respondents, although fewer (44%) were aware of
the logical follow-up to this, that a partner who has or
has had many sexual partners is also a risk factor. Sig-
nificant differences between doctors and nurse-mid-
wives’ knowledge on all of the items were observed (p <
0.05) (Table 3).
Most respondents did not consider HPV a transient
infection. Only 36% believed that HPV infection is most
often cleared by a competent immune system and does
not usually cause cancer. The more recent graduates
were more likely to be aware of the immune system’s
ability to clear away infection than the older. Most
Table 1 Demographic characteristics of respondents
Characteristics N (%)
Sex
Female 265 (66)
Male 136 (34)
Age-group (years)
Median (range) 38 (20-71)
< 25 70 (17)
26 - 50 218 (54)
> 50 113 (28)
Category of health workers
Medical students 71 (18)
Nursing-midwifery students 38 (10)
Doctors (GP, Ped, Ob-Gyn)* 58 (14)
Nurse-midwives ** 234 (58)
Marital status
Never married 175 (44)
Couple (includes free union, divorced, widowed) 226 (56)
Children
None 136 (34)
< 4 142 (35)
≥ 4 123 (31)
Condom use
Yes 170 (42)
No 166 (41)
Unknown 65 (17)
Screening attitudes among women
Had not had a pap smear in the last 5 years 156 (59)
*GP: general practitioners; Ped: pediatricians; Ob-gyns: obstetricians/
gynecologists (n = 13 (3% of all respondents)).
** Midwives: n = 20 (5% of all respondents)
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Variable Total correct N (%) Medical students N (%) Nursing/Midwifery students N (%) Doctors N (%) Nurses/Midwives N (%) P
HPV is identified in > 50% cervical cancers 242 (60) 57 (81) 16 (42) 47 (81) 122 (52) 0.000
HPV is a sexually transmitted disease 263 (66) 53 (76) 22 (58) 54 (93) 134 (57) 0.005
HPV vaccine helps prevent cervical cancer 177 (44) 42 (59) 12 (32) 41 (71) 82 (35) 0.000
Would recommend vaccine* 157 (89) 37 (88) 11 (92) 37 (90) 72 (88) 0.998
* Among those who believe that the vaccine can prevent cervical cancer.
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7Table 3 Awareness of risk factors, symptoms and screening methods of cervical cancer
Variable Total correct N (%) Medical students N (%) Nursing/Midwifery students N (%) Doctors N (%) Nurses/Midwives N (%) P
Knowledge of 4 most important risk factors
1 231 (58) 48 (67) 16 (41) 52 (90) 115 (49) 0.000
Cervical cancer is preceded by treatable dysplasia 323 (81) 61 (86) 21 (54) 55 (95) 186 (79) 0.019
Dysplasia is usually asymptomatic 174 (43) 43 (61) 14 (38) 46 (79) 71 (30) 0.000
The following test may be used for screening:
- Pap test
2 337 (84) 58 (82) 29 (76) 54 (93) 196 (84) 0.777
- HPV test
3 190 (47) 28 (39) 18 (47) 33 (57) 111 (47) 0.480
- VIA
4 151 (38) 25 (35) 8 (21) 34 (57) 84 (36) 0.001
1 HPV and HIV infections, multiple sexual partners and partner with multiple partners are the most important factors.
2 Pap: Papanicolaou
3 HPV: Human Papillomavirus
4 VIA: visual inspection with acetic acid
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7respondents knew that cervical cancer is preceded by
dysplasia, which can be treated to avoid progression
towards cancer. However, approximately half considered
that HPV infection and dysplasia are generally asympto-
matic (see Table 3).
Pap smear was the most widely and consistently known
screening method for cervical cancer. Other methods
such as VIA or HPV testing were not recognized as such
(Table 3). Screening uptake was surprisingly poor among
healthcare workers more closely involved in women’s
health (59% of women had not had a pap smear in the
last 5 years), (Table 1). Most healthcare workers (75%)
believed the general Cameroonian population is not suffi-
ciently informed about cervical cancer and screening.
More than half (60%) of our respondents believed there
is too little screening because campaigns are irregular
(85% of gynecologists). Many respondents (54%) believed
screening uptake in the general population is poor
because it is too expensive (35% disagreed and 11% did
not know).
Only 44% of respondents believed vaccination helps pre-
vent cervical cancer. Most healthcare workers (75%) did
not believe the vaccine had been proven to be effective
yet, but 89% of those who did would recommend it for
young women aged 10-25 years (Table 2).
Discussion
This study was conducted at the same time as the
Cameroon Ministry of Health’s awareness and educa-
tional campaigns, with information on the availability of
cervical cancer screening. Our purpose was to evaluate
knowledge and awareness regarding cervical cancer
screening among Cameroonian healthcare workers
because identification of strengths and weaknesses in
healthcare workers’ knowledge may be crucial in targeted
information campaigns.
We found the level of knowledge in our study sample to
be comparable to studies of similar populations in other
developing countries. A study conducted in Thailand in
2009 [9] found that 82% of nurses and 88% of doctors
interviewed believed HPV to be a public health issue (as
did 86% of our sample).
The Ministry of Health has informed the population
that screening will be offered to women free of charge.
However, cost is still an oft-cited reason for poor use of
screening services by the general population. This is cer-
tainly a factor in rural settings, where cost of transport
and time spent away from work add to the actual cost
of screening. Offering more geographically accessible
health facilities may effectively increase screening uptake
[10]. Nevertheless, geographical access may only be a
partial explanation, since among well-informed health-
care workers, for whom screening was free and provided
in the workplace, uptake of these services was low, with
more than 60% of women never having been screened
(or not in the last 5 years). Other barriers to screening
included “not feeling sick” [11,12] and “not feeling at
risk” [12,13]. Although a positive association between
women’s knowledge about cervical cancer and the likeli-
hood of her having a Pap smear has been found [14],
poor uptake of screening services among the better-
informed healthcare workers[12,13,15-18], and patients
[19], was a recurrent finding in the studies reviewed and
reasons for this should be further investigated. Recom-
mendation of healthcare providers can also influence
screening behaviour, and providers who lack basic
knowledge may be a problem in this context [7].
Nurse-midwifes are generally the most visible, frontline
personnel of the hospital and are crucial in providing
health education to patients and general population.
However, our data suggest that nurse-midwifes’ levels of
knowledge and understanding of cervical cancer as well
as its preventable nature should be improved. For suc-
cessful screening programs, all healthcare workers must
understand the causative relationship between HPV and
cervical cancer as well as the importance of screening as
a preventive measure. Continuing nurse education may
contribute to strengthening cervical cancer screening
programs.
There is supporting evidence that direct visualization
with acetic acid (VIA) may be a valuable alternative to Pap
smears in areas where access to healthcare is a limitation
[8,20]. However, more recent studies have shown that a
single round of HPV testing might have a greater impact
on the reduction of advanced cervical cancer cases and
associated mortality than VIA or cytology [21]. With ade-
quate infrastructure, HPV testing could be an attractive
alternative to previously used screening methods, as it also
requires fewer hospital visits, and could even be conducted
by patients themselves.
HPV vaccine is a new concept among Cameroonian
healthcare workers. Very few apart from the gynecologists
interviewed were aware the vaccine exists. The inconsis-
tencies in the respondents’ opinions on HPV vaccination
highlight the great confusion surrounding it, its use and
limitations. When compared to the Thai cohort, the
Cameroonian healthcare workers have a similar knowledge
level on HPV, cervical cancer and awareness of its impor-
tance as a public health issue. The respondents in our
study were slightly more likely to recommend HPV vacci-
nation to their patients with 88% of nurses and 90% of
doctors who would recommend vaccination. These figures
were similar to those of a study of HPV vaccine acceptabil-
ity conducted in Brazil [22], which found 82% of physi-
cians and medical students would encourage HPV
vaccination.
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about the vaccine. Although most respondents reacted
positively to the idea of vaccination against HPV, they
expressed concern about the vaccine’s efficacy. It would
be important to ascertain how healthcare workers’ opi-
nion about the vaccine affects health, especially repro-
ductive health.
Conclusion
Among the stronger points of this study, it should be
noted that this is the first study performed in Cameroon
assessing knowledge of cervical cancer screening among
healthcare workers, with a sample sufficiently large to
draw significant conclusions and provide useful pointers
for planning medical education for healthcare workers.
The weaker aspects of the study are that the sample was
not randomly selected, did not include rural health work-
ers and the questionnaires were self-administrated; many
of those distributed were not returned. One could there-
fore expect those who were less confident to have chosen
not to answer. Overall, knowledge may be lower than
appears in this research.
In conclusion, knowledge of cervical cancer and pre-
vention by screening showed several gaps and important
misconceptions. Continuing medical education programs
including nurse-midwives should be conducted at the
hospital level to spread knowledge about cervical cancer
prevention. Healthcare workers including nurse-mid-
wives should be trained to encourage screening. Finally,
further research is needed to explain the reluctance of
eligible healthcare workers to go for screening despite
knowledge about the problem and ready access to
screening facilities. Healthcare workers need to be tar-
geted first because of their pivotal role in any future
screening program.
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